MarketPulse

loop diuretic

2 articles
BenzingaBenzinga··Na

Esperion Closes Corstasis Acquisition, Adds First Nasal Spray Loop Diuretic to CV Portfolio

Esperion closes Corstasis acquisition, gaining FDA-approved Enbumyst nasal spray loop diuretic for heart failure treatment, leveraging existing cardiovascular commercial infrastructure.
ESPRacquisitionFDA approval
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Esperion Closes Corstasis Deal, Adding First Nasal Loop Diuretic to Heart Drug Arsenal

Esperion completes acquisition of Corstasis, adding Enbumyst, first FDA-approved nasal spray loop diuretic, to expand its cardiovascular product portfolio.
ESPRacquisitionFDA approval